KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Gross Margin (2016 - 2025)

Bausch Health Companies' Gross Margin history spans 17 years, with the latest figure at 105.15% for Q4 2025.

  • For Q4 2025, Gross Margin fell 790.0% year-over-year to 105.15%; the TTM value through Dec 2025 reached 99.95%, up 357.0%, while the annual FY2025 figure was 99.95%, 1.0% down from the prior year.
  • Gross Margin for Q4 2025 was 105.15% at Bausch Health Companies, up from 99.48% in the prior quarter.
  • Across five years, Gross Margin topped out at 175.75% in Q4 2023 and bottomed at 67.9% in Q4 2021.
  • The 5-year median for Gross Margin is 99.49% (2025), against an average of 96.94%.
  • The largest annual shift saw Gross Margin surged 7598bps in 2023 before it plummeted -6270bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 67.9% in 2021, then soared by 47bps to 99.77% in 2022, then surged by 76bps to 175.75% in 2023, then crashed by -36bps to 113.05% in 2024, then dropped by -7bps to 105.15% in 2025.
  • Per Business Quant, the three most recent readings for BHC's Gross Margin are 105.15% (Q4 2025), 99.48% (Q3 2025), and 98.7% (Q2 2025).